Edesa Biotech, Inc.
Calidad de datos: 83%
EDSA
Nasdaq
Manufacturing
Chemicals
$6.05
▲
$0.09
(1.51%)
Cap. Mercado: 50.51 M
Precio
$6.05
Cap. Mercado
50.51 M
Rango del Día
$5.70 — $6.25
Rango de 52 Semanas
$0.72 — $9.37
Volumen
158,512
Apertura $5.86
Promedio 50D / 200D
$3.60
68.29% above
Promedio 50D / 200D
$2.45
147.04% above
Quick Summary
Puntos Clave
Negative free cash flow of -7.89 M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-55.66%
Below sector avg (-53.41%)
ROIC-47.00%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
N/A
Current Ratio16.82
Interest CoverageN/A
Valoración
PE (TTM)
-6.46
Below sector avg (-1.48)
P/B Ratio3.62
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (1364 pares)
Comparación con Pares
vs mediana del sector Manufacturing (1364 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -6.5 | -1.5 |
| P/B | 3.6 | 1.6 |
| ROE % | -55.7 | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -7.82 M |
| ROE | -55.66% | ROA | -52.96% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -7.89 M |
| ROIC | -47.00% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 16.82 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 11.96 M | Tangible Book Value | 12.00 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -6.46 | Forward P/E | N/A |
| P/B Ratio | 3.62 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -15.63% | ||
| Market Cap | 50.51 M | Enterprise Value | 38.41 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | -0.95 | OCF / Share | -0.95 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 100.98% |
| SBC-Adj. FCF | -8.62 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | 0.0 |
| Net Income | -7.19 M | -6.17 M | -8.37 M | -17.55 M | -13.34 M |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -7.91 M | -7.01 M | -9.22 M | -18.37 M | -23.68 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 3.67 M | 2.88 M | 4.79 M | 13.34 M | 17.95 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 119,273.0 | 186,049.0 | 183,471.0 | 118,188.0 | 118,788.0 |
| Interest Expense | — | — | — | — | — |
| Income Tax | 800.0 | 800.0 | 800.0 | 800.0 | 800.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 13.53 M | 3.81 M | 8.89 M | 11.58 M | 14.58 M |
| Total Liabilities | — | 1.83 M | 1.84 M | 2.18 M | 1.53 M |
| Shareholders' Equity | 12.45 M | 1.98 M | 7.05 M | 9.39 M | 13.06 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 10.80 M | 1.00 M | 5.40 M | 7.09 M | 7.84 M |
| Current Assets | 11.51 M | 1.68 M | 6.44 M | 9.09 M | 12.09 M |
| Current Liabilities | 1.08 M | 1.83 M | 1.82 M | 2.14 M | 1.46 M |
{"event":"ticker_viewed","properties":{"ticker":"EDSA","listing_kind":"stock","pathname":"/stocks/edsa","exchange":"Nasdaq","country":"US"}}